News
MTS Medication Technologies, Inc. Completes Merger with Excellere Partners
ST. PETERSBURG, Fla. - December 22, 2009 - MTS Medication Technologies, Inc. (NasdaqCM:MTSI), an international provider of medication adherence packaging systems, today announced the completion of its previously announced merger with an affiliate of Excellere Partners, LLC. At a special meeting held on December 18, 2009, the stockholders of MTS voted to approve the Agreement and Plan of Merger that MTS entered into on August 7, 2009. Under the terms of the merger agreement, MTS stockholders are entitled to receive $5.75 in cash, without interest, for each share of MTS common stock held. Effective as of the closing of the market today, MTS common stock will cease to be traded on the NASDAQ Stock Market. Continue